| Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer GHJM Leyten, D Hessels, SA Jannink, FP Smit, H de Jong, EB Cornel, ... European urology 65 (3), 534-542, 2014 | 474 | 2014 |
| Detection of high-grade prostate cancer using a urinary molecular biomarker–based risk score L Van Neste, RJ Hendriks, S Dijkstra, G Trooskens, EB Cornel, ... European urology 70 (5), 740-748, 2016 | 436 | 2016 |
| The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance MPMQ van Gils, D Hessels, O van Hooij, SA Jannink, WP Peelen, ... Clinical cancer research 13 (3), 939-943, 2007 | 266 | 2007 |
| Identification of a candidate gene panel for the early diagnosis of prostate cancer GHJM Leyten, D Hessels, FP Smit, SA Jannink, H de Jong, WJG Melchers, ... Clinical cancer research 21 (13), 3061-3070, 2015 | 262 | 2015 |
| Predictive value of PCA3 in urinary sediments in determining clinico‐pathological characteristics of prostate cancer D Hessels, MPMQ van Gils, O van Hooij, SA Jannink, JA Witjes, ... The Prostate 70 (1), 10-16, 2010 | 246 | 2010 |
| Prostate cancer biomarker profiles in urinary sediments and exosomes S Dijkstra, IL Birker, FP Smit, GHJM Leyten, TM de Reijke, IM van Oort, ... The Journal of urology 191 (4), 1132-1138, 2014 | 157 | 2014 |
| The anaerobic chytridiomycete fungus Piromyces sp. E2 produces ethanol via pyruvate:formate lyase and an alcohol dehydrogenase E B Boxma, F Voncken, S Jannink, T Van Alen, A Akhmanova, ... Molecular microbiology 51 (5), 1389-1399, 2004 | 133 | 2004 |
| Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes RJ Hendriks, S Dijkstra, SA Jannink, MG Steffens, IM van Oort, ... Clinical Chemistry and Laboratory Medicine (CCLM) 54 (3), 483-492, 2016 | 87 | 2016 |
| Rational basis for the combination of PCA3 and TMPRSS2: ERG gene fusion for prostate cancer diagnosis G Robert, S Jannink, F Smit, T Aalders, D Hessels, R Cremers, ... The Prostate 73 (2), 113-120, 2013 | 83 | 2013 |
| Differential expression of PCA3 and its overlapping PRUNE2 transcript in prostate cancer M Salagierski, GW Verhaegh, SA Jannink, FP Smit, D Hessels, ... The Prostate 70 (1), 70-78, 2010 | 64 | 2010 |
| Prevalence of human xenotropic murine leukemia virus‐related gammaretrovirus (XMRV) in Dutch prostate cancer patients GW Verhaegh, AS de Jong, FP Smit, SA Jannink, WJG Melchers, ... The Prostate 71 (4), 415-420, 2011 | 58 | 2011 |
| The role of HOXC6 in prostate cancer development ARAH Hamid, AM Hoogland, F Smit, S Jannink, ... The Prostate 75 (16), 1868-1876, 2015 | 54 | 2015 |
| KLK3, PCA3, and TMPRSS2‐ERG expression in the peripheral blood mononuclear cell fraction from castration‐resistant prostate cancer patients and response to docetaxel treatment S Dijkstra, GHJM Leyten, SA Jannink, H de Jong, PFA Mulders, ... The Prostate 74 (12), 1222-1230, 2014 | 43 | 2014 |
| Biomarkers for the diagnosis of prostatic inflammation in benign prostatic hyperplasia G Robert, F Smit, D Hessels, S Jannink, HFM Karthaus, T Aalders, ... The Prostate 71 (15), 1701-1709, 2011 | 32 | 2011 |
| Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma K Nagao, N Shinohara, F Smit, M De Weijert, S Jannink, Y Owada, ... BMC cancer 18, 1-11, 2018 | 30 | 2018 |
| High‐resolution ERG‐expression profiling on GeneChip exon 1.0 ST arrays in primary and castration‐resistant prostate cancer FP Smit, M Salagierski, S Jannink, JA Schalken BJU international 111 (5), 836-842, 2013 | 16 | 2013 |
| Molecular markers in prostate cancer FP Smit, JA Schalken, D Hessels, SA Jannink US Patent App. 13/122,226, 2012 | 16 | 2012 |
| Analytical validation of an mRNA-based urine test to predict the presence of high-grade prostate cancer D Hessels, H de Jong, SA Jannink, M Carter, M Krispin, W Van Criekinge, ... Translational Medicine Communications 2, 1-12, 2017 | 8 | 2017 |
| Elevated HOXC6/DLX1 mRNA biomarker levels in urine to help select patients at increased risk for high-grade prostate cancer detection upon prostate biopsy. R Hendriks, S Dijkstra, EB Cornel, S Jannink, H de Jong, D Hessels, ... Journal of Clinical Oncology 34 (2_suppl), 31-31, 2016 | 3 | 2016 |
| 1708: The Time Resolved Fluorescence-Based PCA3 Test on Urinary Sediments after Extended Digital Rectal Examination; a Dutch Multicenter Validation of the Diagnostic Performance MP van Gils, D Hessels, O van Hooij, SA Jannink, W Pim Peelen, ... The Journal of Urology 177 (4S), 568-568, 2007 | 3 | 2007 |
